Denisa Wilkes 1/9/25 Denisa Wilkes 1/9/25

Safety and pharmacokinetics of single and multiple ascending doses of ALG-097558, a pan-coronavirus 3CL protease inhibitor, and relative bioavailability/food effect of a solid formulation…

Wataru Sugiura 1/9/25 Wataru Sugiura 1/9/25

COVID-19 Relapse and Viral Evolution in a Good Syndrome Patient: A Case Study

Nicholas C. Riola 1/9/25 Nicholas C. Riola 1/9/25

In vitro antiviral activity of obeldesivir and GS-441524 in combination with oral SARS-CoV-2 therapeutics nirmatrelvir/ritonavir or molnupiravir

Jeffery J Niesen 1/9/25 Jeffery J Niesen 1/9/25

Novel Ligand-Targeted Immunotherapy for the treatment of Human Respiratory Syncytial Virus

Conrrad Nicholls 1/9/25 Conrrad Nicholls 1/9/25

A Small Molecule Based Bispecific Antigenic Immunotherapy for the treatment of Dengue

Mahta Mortezavi 1/9/25 Mahta Mortezavi 1/9/25

Virologic Response and Safety After Oral Administration of PF-07817883, a Novel SARS-CoV-2 Mpro inhibitor, in Nonhospitalized Adults With Symptomatic COVID-19

David C. McGowan 1/9/25 David C. McGowan 1/9/25

Discovery and Preclinical Profile of ALG-097558, a SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19

Sonia Mathew 1/9/25 Sonia Mathew 1/9/25

Ocular Monkeypox Infection Leading to Vision Impairment in a 42-Year-Old Male with Well-Controlled HIV

Johan Lennerstrand 1/9/25 Johan Lennerstrand 1/9/25

Identification of inhibitors against the proteases of Dengue virus and other flaviviruses using a novel AI tool for drug discovery

William Colton 1/9/25 William Colton 1/9/25

Advancing Rapid Point-of-Care Diagnostics and Bacteriophage Therapeutics for Drug-Resistant Bacterial Infections

Samantha M.Y. Chen 1/9/25 Samantha M.Y. Chen 1/9/25

Novel Multiplex qRT-PCR Assay to Classify and Quantify Respiratory Syncytial Virus

Andrea Cox 12/24/24 Andrea Cox 12/24/24

Systems immunology defines immunological profiles associated with long COVID onset and recovery

Dario Akaberi 12/24/24 Dario Akaberi 12/24/24

Exhaustive characterization of the broad-spectrum activity of flavivirus protease inhibitors

Dharmeshkumar Patel 12/24/24 Dharmeshkumar Patel 12/24/24

In Silico Discovery of Broad-spectrum Antivirals Targeting Viral Protease

Barbara Nery Porto 12/24/24 Barbara Nery Porto 12/24/24

Mechanisms of respiratory syncytial virus-induced cell death

Asuncion Mejias 12/24/24 Asuncion Mejias 12/24/24

A change in the paradigm for the prevention of RSV in infants and young children

Peter Palese 12/24/24 Peter Palese 12/24/24

Unraveling pathways of viral disease emergence

Vincent Marconi 12/24/24 Vincent Marconi 12/24/24

Aging from COVID-19

Ana Bolio 12/24/24 Ana Bolio 12/24/24

Strengthening Vaccine Confidence: Key Factors, Strategies, and Future Directions

Dirk Jochmans 12/24/24 Dirk Jochmans 12/24/24

Inhibitors of SARS-CoV-2 Assembly